Hjem › Kræft (alle typer) › Rhode Island
Kræft (alle typer) kliniske forsøg i Rhode Island
12 studier for Kræft (alle typer) søger deltagere på steder i Rhode Island.
Byer i Rhode Island
Officiel studietekst (engelsk)
A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
- Women & Infants Hospital /ID# 277930, Providence
RekruttererFase 2
Alder 18 og opefter · Kvinder · Opdateret 1. okt. 2026 · NCT07024784TLR9 Immunotherapy for Peritoneal Carcinomatosis
- Rhode Island and the Miriam Hospitals (Brown University Health), Providence
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 1. okt. 2026 · NCT07658196Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care
- Brown University Health, Providence
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 25. sep. 2026 · NCT07195591A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
- Rhode Island Hospital, Providence
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 24. sep. 2026 · NCT06901531A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- Lifespan Cancer Institute, Providence
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 8. sep. 2026 · NCT06119581Project: Every Child for Younger Patients With Cancer
- Rhode Island Hospital, Providence
RekruttererObservationsstudie
Op til 25 år · Alle køn · Opdateret 25. aug. 2026 · NCT02402244A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
- Lifespan Cancer Institute, Providence
RekruttererFase 2
Alder 1 til 39 · Alle køn · Opdateret 7. aug. 2026 · NCT05999994Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
- Women and Infants Hospital, Providence
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 7. aug. 2026 · NCT06580314Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
- Lifespan Cancer Institute at Rhode Island Hospital /ID# 225705, Providence
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 4. jun. 2026 · NCT04777994Primary Tumor Research and Outcomes Network
- Rhode Island Hospital, Providence
RekruttererObservationsstudie
Alle aldre · Alle køn · Opdateret 25. feb. 2026 · NCT02790983Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial Cancer
- Women & Infants Hospital, Providence
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 13. nov. 2025 · NCT05997017SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Providence
RekruttererObservationsstudie
Alle aldre · Alle køn · Opdateret 28. okt. 2025 · NCT03452774Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.